- Home
- QMCO vs GOSS Comparison
QMCO vs GOSS Comparison
Compare QMCO & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMCO
- GOSS
- Stock Information
- Founded
- QMCO 1980
- GOSS 2015
- Country
- QMCO United States
- GOSS United States
- Employees
- QMCO N/A
- GOSS N/A
- Industry
- QMCO Electronic Components
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- QMCO Technology
- GOSS Health Care
- Exchange
- QMCO Nasdaq
- GOSS Nasdaq
- Market Cap
- QMCO 263.9M
- GOSS 237.9M
- IPO Year
- QMCO N/A
- GOSS 2019
- Fundamental
- Price
- QMCO $32.60
- GOSS $0.96
- Analyst Decision
- QMCO Hold
- GOSS Strong Buy
- Analyst Count
- QMCO 2
- GOSS 5
- Target Price
- QMCO $5.00
- GOSS $9.20
- AVG Volume (30 Days)
- QMCO 4.1M
- GOSS 1.0M
- Earning Date
- QMCO 01-24-2025
- GOSS 03-04-2025
- Dividend Yield
- QMCO N/A
- GOSS N/A
- EPS Growth
- QMCO N/A
- GOSS N/A
- EPS
- QMCO N/A
- GOSS N/A
- Revenue
- QMCO $285,238,000.00
- GOSS $105,322,000.00
- Revenue This Year
- QMCO N/A
- GOSS N/A
- Revenue Next Year
- QMCO N/A
- GOSS N/A
- P/E Ratio
- QMCO N/A
- GOSS N/A
- Revenue Growth
- QMCO N/A
- GOSS N/A
- 52 Week Low
- QMCO $2.22
- GOSS $0.50
- 52 Week High
- QMCO $90.64
- GOSS $1.60
- Technical
- Relative Strength Index (RSI)
- QMCO 48.49
- GOSS 54.23
- Support Level
- QMCO $19.31
- GOSS $0.83
- Resistance Level
- QMCO $38.90
- GOSS $1.18
- Average True Range (ATR)
- QMCO 9.02
- GOSS 0.10
- MACD
- QMCO -3.21
- GOSS -0.01
- Stochastic Oscillator
- QMCO 18.63
- GOSS 41.37
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.